In pre-metastatic bone, RANK/RANKL signalling creates an osteolytic PMN through the facilitation of pre-osteoclast maturation, which induces the release of soluble and insoluble factors from the skeleton, supporting cancer growth and survival in bone [66, 67]. The gene discussed is TNFSF11; the disease is cancer.